EBSCO Research | Research

Current News

Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab

Optimizing COVID-19 treatment in immunocompromised patients: early combination therapy with remdesivir, nirmatrelvir/ritonavir and sotrovimab 2023-12-16 04:00:00

Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies

Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies 2023-12-16 04:00:00

Removing home hazards for older adults living in affordable housing: A stepped-wedge cluster-randomized trial

Removing home hazards for older adults living in affordable housing: A stepped-wedge cluster-randomized trial 2023-12-16 04:00:00

Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation

Optimal timing of nirmatrelvir/ritonavir treatment after COVID-19 symptom onset or diagnosis: target trial emulation 2023-12-16 04:00:00

Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccination

Characterization of SARS-CoV-2-specific humoral immunity and associated factors in the healthy population post-vaccination 2023-12-16 04:00:00